Search
Powered By HealthLine
Health Tools
 Mood Tracker
 Heart Healthy Diet
 Ideal Body Weight Calculator
 Diet Reviews
 Fitness and Family
 Quiz: Test Your Fitness IQ
 Exercise and Fitness Guide
 Eat Out Smart
 Healthy Cooking
 BMI Calculator
Featured Conditions
 Diet & Exercise
 Stop Smoking
 Food & Fitness
 High Blood Pressure
 Cholesterol
 Heart
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Discovery Links Genes to Pancreatic Cancer

Researchers must still determine how to use the data to reduce risk

By Amanda Gardner
HealthDay Reporter


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Basal Cell Carcinoma
Bladder Cancer
Bone Cancer
More...

Related Healthscout Videos
 border=
Growing Lungs in the Lab: Medicine's Next Big Thing?
From Belly to Breast: Rebuilding After Cancer
Shaving off Cancer
Fluorescent Medicine for Brain Tumors
More...

Related Animations
 border=
Breast Self-Exam Video
Colon Cancer
More...

Related Drug Information
 border=
Epogen
Iressa
Procrit
Topamax
More...

Related News Articles
 border=
Damage of 'False-Positive' Mammograms Overlooked: Study
Smoking Scenes in Movies Light Up Smokers' Brains
Gene Test Might Predict Colon Cancer's Return
Breast Cancer Radiation Before 1984 Tied to Heart Disease
More...

MONDAY, Jan. 25 (HealthDay News) -- Researchers have identified four regions of the human genome that predict a heightened risk of pancreatic cancer as a result of what they describe as the biggest-ever sweep of the genome for genes related to the disease.

Though some of the locations had been linked to other cancers, the discovery of others apparently surprised the researchers.

Text Continues Below



"This lets us go places we had never thought of before," said senior study author Dr. Stephen Chanock, chief of the laboratory of translational genomics at the U.S. National Cancer Institute.

However, he cautioned that though the regions "are conclusively associated with the risk of developing pancreatic cancer, it doesn't mean if you have a variation in that region you're going to get pancreatic cancer."

It simply means risk is increased, and, more than likely, environmental factors would have to come into play to complete the picture, he explained.

The findings were reported online Jan. 24 in Nature Genetics.

Pancreatic cancer has an extremely grim prognosis, with only 5 percent of people still alive five years after detection.

"Pancreatic cancer is often diagnosed at a very late stage, and that's partly due to anatomical location," Chanock said. "The disease can fester and grow for extended periods of time before it impinges on a vital structure that produces symptoms, and we have not developed sufficiently good ways to identify people at risk with tests."

Smoking, a history of diabetes and weight problems all can contribute to risk, as can a family history of the disease, although family clusters account for less than 5 percent to 10 percent of all pancreatic cancers, he added.

But only recently have scientists begun to unravel the myriad genetic factors that might trigger the disease.

After analyzing genes in close to 4,000 people with pancreatic cancer and an equivalent number of people without the disease, the investigators identified three genetic regions associated with a greater risk for the cancer.

Page:  1 | 2 | Next >>

Copyright © 2010 HealthDay. All rights reserved.
Last updated 1/25/2010

Related Links
 border=
From Healthscout's partner site on alzheimer's disease, OurAlzheimers.com
I need to know about Alzheimer's symptoms.
What are the stages of Alzheimer's Disease?
Learn about Alzheimer's medications.




SOURCES: Stephen Chanock, M.D., chief, laboratory of translational genomics, U.S. National Cancer Institute, Bethesda, Md.; Michael Hall, M.D., director, gastrointestinal cancer risk assessment program, Fox Chase Cancer Center, Philadelphia; Jan. 24, 2010, Nature Genetics, online


HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2011. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire